No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Have Insiders Sold Cullinan Therapeutics Shares Recently?
Clear Street Launches Healthcare & Biotechnology Equity Research
Top Premarket Decliners
Adobe, Keros Therapeutics, Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Cullinan Therapeutics Announces Q3 2024 Progress and Outlook
We're Not Very Worried About Cullinan Therapeutics' (NASDAQ:CGEM) Cash Burn Rate